ADHERTENCE AND COMPLIANCE TO TREATMENTS
|
|
- Marjory Cannon
- 5 years ago
- Views:
Transcription
1 ADHERTENCE AND COMPLIANCE TO TREATMENTS Sobhi DADA, MD, FACC, FESC Consultant cardiology Hammoud Hospital- University medical center Saida, Lebanon
2 Adherence Mosby s Medical Dictionary defines adherence as the process in which a person follows rules, guidelines, or standards, especially as patients follow a prescription and recommendations for a regimen of care
3
4 Medication adherence The degree to which the person s behavior corresponds with the agreed recommendations from a health care provider. World Health Organization
5
6 Chronic Care Model
7 Global Medication Adherence is 50%
8 Medication adherence 22% of U.S. patients take less of the medication than is prescribed American Heart Association: Statistics you need to know. Accessed November 21, 2007.
9 Percent of patients continually refilling Rx Adherence to statins after two years, by condition 50% 40% 30% 20% 10% 0% 40% Acute coronary syndrome 36% Chronic coronary artery disease 24% Primary prevention Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288:
10 Why adherence matters Of all medication-related hospital admissions in the United States, 33 to 69 percent are due to poor medication adherence, with a resultant cost of approximately $100 billion a year. Results of failure to adhere to prescribed medications: Increased hospitalization Poor health outcomes Increased costs Decreased quality of life Patient death Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:
11 Annual per-patient health care costs Poor adherence increases total health care costs Hypertensive Patients and Total Annual Costs $12,000 $10,000 $8,000 $6,000 $4,000 $2,000 $0 $4,850 Received meds, 100% compliant $6,400 Purchased some, but took all purchased $10,500 Purchased some, taken irregularly Smith DL. The effect of patient noncompliance on health care costs. Medical Interface 1993:April; 74-84
12 Why don t patients adhere to their medication therapy? Complex therapies Side Effects Failure to understand the need for the medication High out-of-pocket costs Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:
13 Overcoming barriers to adherence Health plan pays member copay Reduces member out-of pocket costs Emphasizes the importance of continuing therapy Education and outreach Explains the need for medication therapy Breaks down complex therapies into manageable parts Offers strategies for coping with side effects Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:
14 Investment in medication adherence can lead to dramatic reductions in overall cost of care Average health care expenditures per year ($) $10,000 $55 $8,000 $165 $285 $404 $6,000 $763 $8,812 $4,000 $6,959 $6,237 $5,887 $2,000 $3,808 $0 1-19% 20-39% 40-59% 60-79% % Diabetes Medication Level of Adherence (% days supply/year) Rx $ Medical $ Outcome is significantly higher than outcome for % adherence group (P<0.05). Differences were tested for medical cost and hospitalization risk. Sokol M et al. Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost. Medical Care. Volume 43, Number 6, June 2005
15
16
17
18
19
20 WHO s Five Dimensions of Adherence
21 Self-Management
22
23
Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help
Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help William Shrank MD MSHS Division of Pharmacoepidemiology & Pharmacoeconomics Harvard Medical School wshrank@partners.org
More informationCLINICAL. Determinants of Compliance With Statin Therapy and Low-Density Lipoprotein Cholesterol Goal Attainment in a Managed Care Population
Determinants of Compliance With Statin Therapy and Low-Density Lipoprotein Cholesterol Goal Attainment in a Managed Care Population Jennifer S. Schultz, PhD; John C. O Donnell, PhD; Ken L. McDonough, MD;
More informationAs a result of its prevalence and cost, cardiovascular disease
Benjamin J. Ansell, MD, FACP/FACC ABSTRACT BACKGROUND: Cardiovascular disease is characterized by significant prevalence and cost in the managed care setting. Despite overwhelming evidence in favor of
More informationDisclosure. Learning Objectives 6/4/2014. Medication Adherence: Challenges and Opportunities
Medication Adherence: Challenges and Opportunities Jessica W. Skelley, Pharm D., BCACP Assistant Professor of Pharmacy Practice McWhorter School of Pharmacy, Samford University jmwhalen@samford.edu Disclosure
More informationRESEARCH. Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data
1 Screening and Test Evaluation Program (STEP), School of Public Health, University of Sydney, NSW 26, Australia 2 NHMRC Clinical Trials Centre, University of Sydney 3 Centre for Research in Evidence Based
More informationMEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL
MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL JENNIFER BUSSELL MD FACP INSTITUTE FOR HEALTHCARE IMPROVEMENT 15 TH ANNUAL INTERNATIONAL SUMMIT ON IMPROVING PATIENT CARE IN THE OFFICE PRACTICE AND
More informationBy 2030, the number of seniors in the United States
Patient Characteristics and Medication Burden Affect Adherence Among Seniors Drug Trends R. Scott Leslie, MPH; Sara C. Erickson, PharmD; and Bimal V. Patel, PharmD, MS By 2030, the number of seniors in
More informationUnderstanding Your Patient Care Opportunity Report (PCOR)
Understanding Your Patient Care Opportunity Report (PCOR) Use your January/February 208 PCOR to help improve performance on Medicare Part D Clinical Star Ratings measures. Your January/February 208 Patient
More informationThe important role of cholesterol in the development
Research Recherche The use of cholesterol-lowering medications after coronary revascularization James M. Brophy, Chantal Bourgault, Paul Brassard Abstract Background: In clinical trials, cholesterol-lowering
More informationPeriodic Rosuvastatin or Atorvastatin Dosing Arrays (PRADA): Patient-Centered Practice
Drugs R D (2014) 14:221 225 DOI 10.1007/s40268-014-0061-9 ORIGINAL RESEARCH ARTICLE Periodic Rosuvastatin or Atorvastatin Dosing Arrays (PRADA): Patient-Centered Practice Theodore Christou Hesham R. Omar
More informationTo Take or Not To Take?
To Take or Not To Take? Assessment Question How do the terms adherence & compliance differ? 1. The terms are synonymous 2.Adherence assumes collaboration between patient & provider while compliance suggests
More informationTrends in adherence to secondary prevention medications in elderly post-myocardial infarction patients y
pharmacoepidemiology and drug safety 2008; 17: 1189 1196 Published online 27 October 2008 in Wiley InterScience (www.interscience.wiley.com).1671 ORIGINAL REPORT Trends in adherence to secondary prevention
More informationCLINICAL. The Effect of Switching on Compliance and Persistence: The Case of Statin Treatment
The Effect of Switching on Compliance and Persistence: The Case of Statin Treatment Patrick Thiebaud, PhD; Bimal V. Patel, PharmD; Michael B. Nichol, PhD; and David M. Berenbeim, MD Objective: To determine
More informationGetting Hypertension Under Control
Getting Hypertension Under Control Learning Objectives EXPLAIN the factors involved in patient medication non-adherence. OUTLINE the results of studies focusing on medication adherence issues in patients
More informationPatterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents
Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents Dennis T. Ko, MD, MSc, a,b Maria Chiu, MSc, b Helen Guo, MSc, b Peter
More informationENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS
ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS Philip J. Schneider, MS, FASHP The University of Arizona College of Pharmacy Learning Objectives: Describe the medication-use system and all interdependent
More informationEconomics of Reducing Out-of-Pocket Costs for Cardiovascular Preventive Services for Patients with High Blood Pressure and High Cholesterol
s of Reducing Out-of-Pocket Costs for Cardiovascular Preventive Services for Patients with High Blood Pressure and High Cholesterol Summary Evidence Tables Study Author (Year) Bunting (2008) Prepost Incomplete
More informationKidney Function and Long-Term Medication Adherence after Myocardial Infarction in the Elderly
Article Kidney Function and Long-Term Medication Adherence after Myocardial Infarction in the Elderly Tara I. Chang,* Manisha Desai, Daniel H. Solomon, and Wolfgang C. Winkelmayer* Summary Background and
More informationPotential synergy between lipid-lowering and blood-pressure-lowering, and Single pill benefit in patient s adherence
Potential synergy between lipid-lowering and blood-pressure-lowering, and Single pill benefit in patient s adherence Park, Chang Gyu Korea University Guro Hospital ASCOT-BPLA and LLA Primary Objectives
More informationMoving the Needle: How Are We Doing with Patient Adherence to Drug Therapy?
Moving the Needle: How Are We Doing with Patient Adherence to Drug Therapy? 2018 Patient Adherence Influence Report By Mike Occhipinti and Linda Morini 2018 Syneos Health. All rights reserved. MOVING THE
More informationPersistence With Lipid-Lowering Therapy: Influence of the Type of Lipid-Lowering Agent and Drug Benefit Plan Option in Elderly Patients
ORIGINAL RESEARCH Persistence With Lipid-Lowering Therapy: Influence of the Type of Lipid-Lowering Agent and Drug Benefit Plan Option in Elderly Patients SUSAN M. ABUGHOSH, PhD; STEPHEN J. KOGUT, RPh,
More informationLeveraging Information Technology for Evidence-Based Design. December 15, 2005
Leveraging Information Technology for Evidence-Based Design December 15, 2005 Introduction ActiveHealth Management Technology Evidence Based Formulary Program Lessons Learned 2 ActiveHealth Management
More informationCost-Related Medication Underuse: Prevalence Among Hospitalized Managed Care Patients
ORIGINAL RESEARCH Cost-Related Medication Underuse: Prevalence Among Hospitalized Managed Care Patients Niteesh K. Choudhry, MD, PhD 1 *, Uzaib Y. Saya, BA 1, William H. Shrank, MD, MSHS 1, Jeffrey O.
More informationSLEEP SOLUTION. AIM Insights
SLEEP SOLUTION AIM Insights Protecting sleep health: The cost when Americans ignore sleep disorder treatment How AIM is leveraging data to identify gaps in clinical care and reduce health care spending
More informationIntervention to improve adherence to Type 2 Diabetes mellitus subjects in rural teaching hospital
Available online at wwwscholarsresearchlibrarycom Scholars Research Library Der Pharmacia Lettre, 2016, 8 (1):361-367 (http://scholarsresearchlibrarycom/archivehtml) ISSN 0975-5071 USA CODEN: DPLEB4 Intervention
More informationPrescription Switching and Reduced LDL-C Goal Attainment
Prescription Switching and Reduced LDL-C Goal Attainment JoAnne M. Foody, MD, FACC, FAHA Brigham and Women's Hospital, Boston, MA Disclosures Consultant for Merck and Pfizer Why Address Adherence? Increasing
More informationDyslipidemia Treatment in 2016 Novel Agents Combination Therapies Statin Intolerance
Dyslipidemia Treatment in 2016 Novel Agents Combination Therapies Statin Intolerance Hani Sabbour MD FACC FHRS Clinical Assistant Professor of Cardiology Brown University Rhode Island USA Consultant Cardiology
More informationEfforts to redesign the healthcare system are increasingly focused
A Blueprint for Pharmacy Benefit Managers to Increase Value William H. Shrank, MD, MSHS; Michael E. Porter, PhD, MBA; Sachin H. Jain, MD, MBA; and Niteesh K. Choudhry, MD, PhD Managed Care & ealthcare
More informationAn advisory committee to the U.S. Food and Drug
Perspective Over-the-Counter Statins Niteesh K. Choudhry, MD, PhD, and Jerry Avorn, MD In late 2004, the British government decided to allow a lipidlowering agent to be sold as an over-the-counter medication.
More informationConcordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report Medication Adherence Scale
Chapman University Chapman University Digital Commons Pharmacy Faculty Articles and Research School of Pharmacy 10-13-2014 Concordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report
More informationPoor blood pressure control substantially increases the risk of
Effect of Patient Comorbidities on Filling of Antihypertensive Prescriptions Tara Lagu, MD, MPH; Mark G. Weiner, MD; Susan Eachus, PhD; Simon S. K. Tang, MPH; J. Sanford Schwartz, MD; and Barbara J. Turner,
More informationCalculating Risk for Primary Prevention of Cardiovascular Disease (CVD)
Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD) 2. Welcome by Stacey Sheridan, MD, MPH Hello. My name is Stacey Sheridan, and I m here as your partner in Heart Health Now. The North
More informationOR OTHER RELATIONSHIP(S) DISCLOSURE:
Gregory Roth, MD DISCLOSURE DECLARATION Medication Adherence in Cardiovascular Disease: Drugs Don t Work in Patients Who Don t Take Them FINANCIAL OR OTHER RELATIONSHIP(S) DISCLOSURE: St. Charles Medical
More informationIMPACT OF PILL BURDEN AND SOCIO-ECONOMIC STATUS OF PATIENTS ON ADHERENCE TO PHARMACOLOGIC THERAPY IN ELDERLY
The West London Medical Journal 2014 Vol 6 No 1 pp 23-28 IMPACT OF PILL BURDEN AND SOCIO-ECONOMIC STATUS OF PATIENTS ON ADHERENCE TO PHARMACOLOGIC THERAPY IN ELDERLY Anil Kumar Jeetendra Kumar Balakrisnan
More informationHow pharmacy and retail health can support health and wellness. Nancy Gagliano Chief Medical Officer, MC September, 2014
How pharmacy and retail health can support health and wellness Nancy Gagliano Chief Medical Officer, MC September, 2014 2 An important decision for public health Current Health Care Challenges The State
More informationImproving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies
Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies Megan Willson, PharmD, BCPS; Catrina Schwartz, PharmD, BS; Jennifer Robinson, PharmD Spokane,
More informationAdherence and persistence with prescribed chronic medications
RESEARCH Impact of Appointment-Based Medication Synchronization on Existing Users of Chronic Medications David Holdford, RPh, MS, PhD, FAPhA, and Kunal Saxena, BS, MS ABSTRACT BACKGROUND: Appointment-based
More informationOral Self Care By P. Weinstein;T. Getz
Oral Self Care By P. Weinstein;T. Getz Behaviour management guidelines - Jul 28, 2015 recognizes that, in providing oral health care for infants, and self-confident in the dental 15. Weinstein P, Getz
More informationThe Nanos Survey on Drug Affordability is Flawed. Here s Why.
The Nanos Survey on Drug Affordability is Flawed. Here s Why. Michael Law (michael.law@ubc.ca) and Ashra Kolhatkar March 6, 2018 Background Last month, with colleagues we published the largest study to
More informationChronic Disease Management. Mary Rouleau, RN, RD, CDE Condition Management RN The Center
Chronic Disease Management Mary Rouleau, RN, RD, CDE Condition Management RN The Center Chronic Diseases Conditions that: last 1 year or more require ongoing medical attention limit activities of daily
More informationHypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS
Hypertension and the Challenge of Adherence Geneva Clark Briggs, Pharm.D., BCPS Outline Brief overview of HTN and pharmacologic therapies Role of pharmacists in collaboration with patients and physicians
More informationLeverage Healthcare Technology Applications to Improve Primary Nonadherence.
Leverage Healthcare Technology Applications to Improve Primary Nonadherence. Page 2 Medication adherence starts with assessing a patient s opportunity for having positive outcomes on a specific therapy.
More informationImprove the Adherence, Save the Life
Improve the Adherence, Save the Life Park, Chang Gyu Korea University Guro Hospital Cardiovascular Center Seoul, Korea Modifiable CVD Risk Factors Obesity BMI Hypertension Cholesterol LDL HDL Diabetes
More informationShould All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function?
Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function? Avi Shimony, MD, FESC Cardiology Division Soroka University Medical Center Ben-Gurion University, Beer-Sheva Disclosure
More informationPDE File Medication Utilization; Medication Possession Ratio. Kyoungrae Jung, Ph.D. Assistant Professor Penn State University
PDE File Medication Utilization; Medication Possession Ratio Kyoungrae Jung, Ph.D. Assistant Professor Penn State University Outline PDE variables related to medication utilization Measures of medication
More informationSTATINS (3-HYDROXY-3-METHYLglutaryl
ORIGINAL CONTRIBUTION Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary Syndromes Cynthia A. Jackevicius, BScPhm, MSc, FCSHP Muhammad Mamdani, PharmD, MA, MPH Jack V. Tu,
More information16 th Annual IHA Stakeholders Meeting Session 2C
16 th Annual IHA Stakeholders Meeting Session 2C September 19, 2017 Hilton Los Angeles Airport Thank you to our Content Partner: Medication Adherence AppleCare Pharmacy Programs Confidential and proprietary.
More informationAn estimated 23.6 million people in the United States,
Impact of Treatment Complexity on Adherence and Glycemic Control: An Analysis of Oral Antidiabetic Agents Michael Pollack, MS, Benjamin Chastek, MS, Setareh A. Williams, PhD, and Jane Moran, MD Abstract
More informationCost-Effective Process to Improve Drug Adherence for Medicare 5-Star
Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star HEALTH ALLIANCE PLAN Presented by Vanita K. Pindolia, Pharm.D. VP, Ambulatory Clinical Pharmacy Programs_PCM Medicare 5-Star Rating
More informationAbstract. Non-Compliance to Antihypertensive Treatment among Patients Attending Prince Zaid Military Hospital
Non-Compliance to Antihypertensive Treatment among Patients Attending Prince Zaid Military Hospital Lana Sati Goussous (1) Nashat Ayoub Halasah (1) Manhal Halasa (2) (1) Royal medical Services, Jordan
More informationSPECIAL ISSUE. Medicaid Prescription Drug Access Restrictions: Exploring the Effect on Patient Persistence With Hypertension Medications
Medicaid Prescription Drug Access Restrictions: Exploring the Effect on Patient Persistence With Hypertension Medications Jerome Wilson, PhD; Kirsten Axelsen, MS; and Simon Tang, MPH Objective: To compare
More informationHypertension Update 2014:
GSHTP Webinar Hypertension Update 2014: The Kaiser Permanente Northern California Experience Presented by: Marc Jaffe, MD Associate Clinical Professor of Medicine, UCSF Kaiser Permanente Northern California
More informationAddressing the Challenge of Medica3on Adherence. Jan Berger MD, MJ President and CEO Health Intelligence Partners
Addressing the Challenge of Medica3on Adherence Jan Berger MD, MJ President and CEO Health Intelligence Partners Drugs Have Become the Mainstay of Healthcare Treatment America s Other Drug Problem Non-adherence
More informationMedication History. Case 1. Case 1. Case 2. Case 1. Four components of prescribing. Charles Mitchell
Medication History Charles Mitchell Director CSEP, University of Queensland Four components of prescribing Information gathering Clinical decision making Monitor and review Communicate decision - prescribe
More informationPrimary prevention of Cardiovascular Diseases: Differences between European and United States Guidelines
18 MEDICINSKI GLASNIK / str. 18-23 Vojislav Giga 1,2, Marija Petrović 1 Primary prevention of Cardiovascular Diseases: Differences between European and United States Guidelines Abstract: European Society
More informationEVALUATING THE IMPACT OF COST, PERCEIVED BENEFIT AND PERCEIVED VALUE ON PRESCRIPTION DRUG PURCHASING BEHAVIOR. Mahesh Jagannath Fuldeore
EVALUATING THE IMPACT OF COST, PERCEIVED BENEFIT AND PERCEIVED VALUE ON PRESCRIPTION DRUG PURCHASING BEHAVIOR Except where reference is made to the work of others, the work described in this thesis is
More informationRole of the Clinical Pharmacist in Primary Care
Role of the Clinical Pharmacist in Primary Care Amy Kramer, Pharm.D., Manager Clinical Pharmacy Services Kaiser Permanente Holly Miller, Pharm.D., BCACP, Primary Care Clinical Pharmacist Kaiser Permanente
More informationPanel Discussion: Orals Adherence & Challenges Friday, April 28 th, 2017
Panel Discussion: Orals Adherence & Challenges Friday, April 28 th, 2017 1 2017 Community Oncology Alliance Panel Discussion: Orals Adherence & Challenges Ray Bailey, RPh, Director of Pharmacy Florida
More informationThe University of Mississippi School of Pharmacy
LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA Lokhandwala T. MS, Yang Y. PhD, Thumula V. MS, Bentley J.P.
More informationMedication Therapy Management: Improving Health and Saving Money
Medication Therapy Management: Improving Health and Saving Money Ed Staffa, RPh Vice President, Pharmacy Mirixa Corporation estaffa@mirixa.com July 23, 2008 MTM At A Glance The U.S. health care system
More informationLiteracy and Adherence
Literacy and Adherence Michael Pignone, MD, MPH University of North Carolina-Chapel Hill Department of Medicine A Clinic Visit 54 y.o. woman with DM and HTN returns to clinic 3 months after your last visit
More informationoutcome measures were adherence, medication possession ratio (MPR), persistence, prescription count, and duration of therapy.
ORIGINAL RESEARCH Patient Adherence with HMG Reductase Inhibitor Therapy among Users of Two Types of Prescription Services by T. Jeffrey White, Pharm.D., M.S., Eunice Chang, Ph.D., Scott Leslie, M.P.H.,
More informationThe Problem of CV Drug Adherence Worldwide
The Problem of CV Drug Adherence Worldwide Jose M. Castellano Coordinador Investigaciones Clínicas, Centro Nacional de Investigaciones Cardiovascular (CNIC) Instituto de Salud Carlos III, Madrid, Spain
More informationMedicare Part D was implemented in 2006 to provide prescription
Effects of Coverage Gap Reform on Adherence to Diabetes Medications Feng Zeng, PhD; Bimal V. Patel, PharmD, MS; and Louis Brunetti, MD Objectives: To investigate the impact of Part D coverage gap reform
More informationImprovement of drug adherence using single pill combinations:
Improvement of drug adherence using single pill combinations: what is the evidence? Prof. Michel Burnier Service of Nephrology and Hypertension, CHUV, Lausanne, Switzerland Potentialcauses of non-adherence
More informationCirculation. 2009;119: ; originally published online January 12, 2009; doi: /CIRCULATIONAHA
Impact of a Prescription Copayment Increase on Lipid-Lowering Medication Adherence in Veterans Jalpa A. Doshi, Jingsan Zhu, Bruce Y. Lee, Stephen E. Kimmel and Kevin G. Volpp Circulation. 2009;119:390-397;
More informationRethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands
Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Objectives Identify patient barriers to medication adherence. Describe the clinical and economic impact of
More informationREDUCING COSTS AND IMPROVING HYPERTENSION MANAGEMENT
REDUCING COSTS AND IMPROVING HYPERTENSION MANAGEMENT Vida Stankus 1, Brenda Hemmelgarn 2, Norm RC Campbell 2, Guanmin Chen 2, Finlay A McAlister 1, Ross T Tsuyuki 1 1 EPICORE Centre, Department of Medicine,
More informationApproximately one third of the 15.7 million Americans who are estimated to have diabetes
Diabetes is a very serious illness and too many people are neglecting their condition. Approximately one third of the 15.7 million Americans who are estimated to have diabetes are unaware of their condition.
More informationDespite advances in medical therapy, adherence to medications,
ORIGINAL ARTICLE Patient, Physician, and Payment Predictors of Statin Adherence David C. Chan, MD,* William H. Shrank, MD, MSHS, David Cutler, PhD, Saira Jan, MS, PharmD, Michael A. Fischer, MD, MS, Jun
More informationNORTH CAROLINA STATE HEALTH PLAN FOR TEACHERS AND STATE EMPLOYEES
NORTH CAROLINA STATE HEALTH PLAN FOR TEACHERS AND STATE EMPLOYEES Using Clinical Risk Groups to Focus Board Strategic Initiatives July 26, 2013 Copyright 2013 by The Segal Group, Inc., parent of The Segal
More informationApplying Six Sigma Principles to Drive Healthcare Behavior Change:
Applying Six Sigma Principles to Drive Healthcare Behavior Change: Using Medication Compliance to Improve Healthcare Outcomes Presented by: Todd Prewitt, Director of Clinical Operations/Medical Director,
More informationMedicare Star Ratings and the Shift to Quality- Based Payment Models. David Nau, RPh, PhD, FAPhA PQS President
Medicare Star Ratings and the Shift to Quality- Based Payment Models David Nau, RPh, PhD, FAPhA PQS President The shift to Value-Driven Healthcare The U.S. health care system is rapidly moving to value-based
More informationD. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine
D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine Financial Disclosure I have no relevant financial relationships
More informationEndocrinology: Patient Noncompliance vs. Provider Bias: A Clinical Revelation
Endocrinology: Patient Noncompliance vs. Provider Bias: A Clinical Revelation Pamela Combs, MSN, BC-ANP, CDE 1 Case Study: Bobbi This is a case regarding a patient who presented to the Cleveland Clinic
More informationExhibit 2 - YHP Plan Changes Service YHP Benefit Aetna Durable Medical Equipment including orthotics Prosthetic Devices Home Health Care $ 100 ded/80% to $ 5,000 annual maximum 100% up to $5,000 max Agreed
More information9/25/15. Pharmacy Quality Measures: Financial Support. Learning Objectives. Speaker Disclosure. Access to Preferred Networks and Clinical Performance
Pharmacy Quality Measures: Action Steps for Improvement Financial Support Financial support was provided for this activity through an unrestricted grant from Health Mart Systems, Inc. Christine Jacobson
More informationBehavioral Activation in the Treatment of Depression: An Effective and Efficient Model in the Primary Care Setting
Behavioral Activation in the Treatment of Depression: An Effective and Efficient Model in the Primary Care Setting Presenter Bob Davis, LMSW Claystone Clinical Associates Assistant Adjunct Professor Graduate
More informationPACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION. Chronic Pain and Opiate Management Initiatives
PACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION Chronic Pain and Opiate Management Initiatives Objectives To enhance understanding of current concepts, guidelines and risks of
More informationCondition/Procedure Measure Compliance Criteria Reference Attribution Method
Premium Specialty: Cardiology Credentialed Specialties include: Cardiac Diagnostic, Cardiology, Cardiovascular Disease, Clinical Cardiac Electrophysiology, and Interventional Cardiology This document is
More informationMedication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension
Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Medication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension Hyun-Jin Kim,
More informationImproving medication compliance with ingestible sensors
Improving medication compliance with ingestible sensors BHI 505: Digital Health Presentation By: Joseph Miles, PharmD Reference Moorhead, P., Zavala, A., Kim, Y., & Virdi, N. S. (2017). Science and Practice:
More informationPolypharmacy. A CPPE distance learning programme
A CPPE distance learning programme DLP 177 January 2016 Contents About CPPE distance learning programmes About this learning programme Glossary of key terms v vii ix Contents Section 1 The problem with
More informationSafe, effective, affordable drug choices: online tool for payers and patients.
Executive summary: Rising healthcare costs and greater access to medical information drive patients to seek options for their drug therapy. The MedAlternatives database by Gold Standard/Elsevier empowers
More informationNavigating The Prior Authorization Approval Process. Kristin Webb, RPCA University at Buffalo
Navigating The Prior Authorization Approval Process Kristin Webb, RPCA University at Buffalo Disclosures DISCLOSURES Commercial Entity Relevance Role K. Webb Abbvie Merck, AbbVie, Tobira, Gilead Honorarium
More informationNavigating The Prior Authorization Approval Process
Navigating The Prior Authorization Approval Process Kristin Webb, RPCA University at Buffalo Disclosures DISCLOSURES Commercial Entity Relevance Role K. Webb Abbvie Merck, AbbVie, Tobira, Gilead Honorarium
More informationDigital Technologies: The Solutions to Poor Medication Adherence?
Digital Technologies: The Solutions to Poor Medication Adherence? Jeffrey Mesaros, PharmD Annual Meeting & Exposition Seattle, Washington March 22-25 1 Disclosures The views and opinions expressed in the
More informationMEDAN INTERNATIONAL CONFERENCE ON ADVANCE PHARMACEUTICAL SCIENCES 2014, NOVEMBER 3-4
MEDAN INTERNATIONAL CONFERENCE ON ADVANCE PHARMACEUTICAL SCIENCES 2014, NOVEMBER 3-4 Adherence to Prescribed Medications in Patients with Hypertension in Puskesmas Medan Oleh: Azizah Nasution Khairunnisa
More informationAddressing the Problem of Health Literacy: Practical Approaches in Practice
Addressing the Problem of Health Literacy: Practical Approaches in Practice Darren DeWalt, MD, MPH & Michael Pignone, MD, MPH University of North Carolina-Chapel Hill Department of Medicine Topics Relationship
More informationPediatric Adherence for the School Nurse
Pediatric Adherence for the School Nurse Eve-Lynn Nelson, Ph.D. Assistant Director, Research KU Center for TeleMedicine (913) 588-2413; enelson2@kumc.edu Generously sponsored through a grant from the Health
More informationSujita Narayan. Research in Pharmacoepidemiology National School of Pharmacy, University of Otago
Sujita Narayan Research in Pharmacoepidemiology (RIPE) @ National School of Pharmacy, University of Otago Medication Possession Ratio (MPR) What is MPR? Measure of adherence Ratio of the no. of doses dispensed
More informationBarriers to Achieving A1C Targets: Clinical Inertia and Hypoglycemia. KM Pantalone Endocrinology
Barriers to Achieving A1C Targets: Clinical Inertia and Hypoglycemia KM Pantalone Endocrinology Disclosures Speaker Bureau AstraZeneca, Merck, Novo Nordisk, Sanofi Consultant Novo Nordisk, Eli Lilly, Merck
More informationNoncompliance with Drug Therapy for Chronic Obstructive Pulmonary Disease: A Risk Factor for Hospitalization?
Volume 2 Number 6 1999 VALUE IN HEALTH Noncompliance with Drug Therapy for Chronic Obstructive Pulmonary Disease: A Risk Factor for Hospitalization? Karl Matuszewski, MS, PharmD, 1 Palangat Velayudhan,
More informationThe Un-Special World of Specialty Medications
The Un-Special World of Specialty Medications Manpreet Chahal, PharmD, PhD Oncology Pharmacist, Medical Oncology Associates, Spokane WA Adjunct Clinical Instructor, WSU College of Pharmacy mschahal@wsu.edu
More informationSpending in the United States for prescription drugs was $216.7
Lipid Profile Changes Associated With Changing Available Formulary Statins: Removing Higher Potency Agents Daniel S. Longyhore, PharmD; Casey McNulty Stockton, PharmD; and Marie Roke Thomas, PhD Spending
More informationPerformance Outcomes: Measure & Metric Details
Performance Outcomes: Measure & Metric Details Adherence to Antipsychotic Medications for People with Schizophrenia Numerator: Number of people who remained on an antipsychotic for at least 80% of their
More informationImpact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost Medical Care. 2005;43:521-530. Presented by Rodger Kormylo to the ACSW 11/10/2005 Medco is a registered trademark of Medco Health
More informationThe American healthcare system, particularly the managed
REPORTS Collaborative Care and Motivational Interviewing: Improving Depression Outcomes Through Patient Empowerment Interventions Bill Anderson, PharmD The American healthcare system, particularly the
More informationNonadherence to chronic medications contributes to
BRIEF REPORT Pharmacy-based Interventions to Reduce Primary Medication Nonadherence to Cardiovascular Medications Michael A. Fischer, MD, MS,* Niteesh K. Choudhry, MD, PhD,* Katsiaryna Bykov, PharmD, MS,*
More informationGuideline scope Hypertension in adults (update)
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Hypertension in adults (update) This guideline will update the NICE guideline on hypertension in adults (CG127). The guideline will be
More information